Shionogi Inc, headquartered in Alpharetta, GA, is a global pharmaceutical company dedicated to improving the lives of patients worldwide. With a rich history dating back to 1878, Shionogi is committed to identifying unmet medical needs and harnessing the power of science to develop innovative treatments for challenging human diseases, including antimicrobial resistance and COVID-19.
Driven by a passion for scientific excellence, Shionogi has been at the forefront of discovering and introducing novel antibiotics since 1959. Today, their research and development efforts extend beyond antibiotics to encompass medications for HIV, influenza, and clinical programs targeting diseases with high unmet needs. Through partnerships with industry, government agencies, and early-stage biotechs, Shionogi is dedicated to advancing science and delivering meaningful solutions to patients worldwide.
Generated from the website